drugset / Trial / NCT04977544

Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder

NCT04977544

RandomizedParallel-groupOpen-labelTreatment

Summary

To explore the efficacy of drugs combined with virtual reality exposure therapy in the treatment of phobias compared with single drug treatment.

Timeline

Start
2019-09-01
Primary completion
2022-09-01
Completion
2022-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 200 mg

Indications